{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:05Z","timestamp":1790223125920,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Teva Branded Pharmaceutical Products R&D, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12905-017-0508-6","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T09:30:02Z","timestamp":1516267802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey"],"prefix":"10.1186","volume":"18","author":[{"given":"Rossella E.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Lete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/11538900-000000000-00000","volume":"30","author":"DJ Hooper","year":"2010","unstructured":"Hooper DJ. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin Drug Invest. 2010;30:749\u201363.","journal-title":"Clin Drug Invest"},{"key":"508_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/jwh.2006.0206","volume":"16","author":"AL Nelson","year":"2007","unstructured":"Nelson AL. Communicating with patients about extended-cycle and continuous use of oral contraceptives. J Womens Health (Larchmont). 2007;16:463\u201370.","journal-title":"J Womens Health (Larchmont)"},{"key":"508_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/13625187.2012.684811","volume":"17","author":"A Szarewski","year":"2012","unstructured":"Szarewski A, von Stenglin A, Rybowski S. Women's attitudes towards monthly bleeding: results of a global population-based survey. Eur J Contracept Reprod Health Care. 2012;17:270\u201383.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"508_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.contraception.2006.01.004","volume":"73","author":"S Ferrero","year":"2006","unstructured":"Ferrero S, Abbamonte LH, Giordano M, Alessandri F, Anserini P, Remorgida V, Ragni N. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception. 2006;73:537\u201341.","journal-title":"Contraception"},{"key":"508_CR5","doi-asserted-by":"crossref","unstructured":"Nappi RE, Fiala C, Chabbert-Buffet N, Hausler G, Jamin C, Lete I, Lukasiewic M, Pintiaux A, Lobo P. Women's preferences for menstrual bleeding frequency: results of the inconvenience due to Women's monthly bleeding (ISY) survey. Eur J Contracept Reprod Health Care. 2016;21:242\u201350.","DOI":"10.3109\/13625187.2016.1154144"},{"key":"508_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13625180701800672","volume":"13","author":"F Fruzzetti","year":"2008","unstructured":"Fruzzetti F, Paoletti AM, Lombardo M, Carmignani A, Genazzani AR. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Eur J Contracept Reprod Health Care. 2008;13:153\u20137.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.contraception.2007.02.005","volume":"75","author":"A Edelman","year":"2007","unstructured":"Edelman A, Lew R, Cwiak C, Nichols M, Jensen J. Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception. 2007;75:450\u20133.","journal-title":"Contraception"},{"key":"508_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/13625187.2015.1107894","volume":"21","author":"RE Nappi","year":"2016","unstructured":"Nappi RE, Kaunitz AM, Bitzer J. Extended regimen combined oral contraception: a review of evolving concepts and acceptance by women and clinicians. Eur J Contracept Reprod Health Care. 2016;21:106\u201315.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jfprhc-2013-100600","volume":"40","author":"S Panicker","year":"2014","unstructured":"Panicker S, Mann S, Shawe J, Stephenson J. Evolution of extended use of the combined oral contraceptive pill. J Fam Plann Reprod Health Care. 2014;40:133\u201341.","journal-title":"J Fam Plann Reprod Health Care"},{"key":"508_CR10","first-page":"CD004695","volume":"7","author":"A Edelman","year":"2014","unstructured":"Edelman A, Micks E, Gallo MF, Jensen JT. Grimes DA. Continuous or extended cycle vs cyclic use of combined hormonal contraceptives for contraception Cochrane Database Syst Rev. 2014;7:CD004695.","journal-title":"Continuous or extended cycle vs cyclic use of combined hormonal contraceptives for contraception Cochrane Database Syst Rev"},{"key":"508_CR11","doi-asserted-by":"crossref","unstructured":"Mendoza N, Lobo P, Lertxundi R, Correa M, Gonzalez E, Salamanca A, Sanchez-Borrego R. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies. Eur J Contracept Reprod Health Care. 2014:19:321\u201339.","DOI":"10.3109\/13625187.2014.927423"},{"key":"508_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.contraception.2010.11.015","volume":"84","author":"DL Seval","year":"2011","unstructured":"Seval DL, Buckley T, Kuehl TJ, Sulak PJ. Attitudes and prescribing patterns of extended-cycle oral contraceptives. Contraception. 2011;84:71\u20135.","journal-title":"Contraception"},{"key":"508_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"508_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/aje\/kwi068","volume":"161","author":"JC McGregor","year":"2005","unstructured":"McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD. Utility of the chronic disease score and Charlson Comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol. 2005;161:483\u201393.","journal-title":"Am J Epidemiol"},{"key":"508_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348\u201354.","journal-title":"J Clin Hypertens"},{"key":"508_CR16","volume-title":"User's manual for the SF-36v2\u00ae health survey","author":"Mariush MEEd","year":"2011","unstructured":"Mariush MEEd. User's manual for the SF-36v2\u00ae health survey. 3rd ed. Quality Metric Incorporated: Lincoln, RI; 2011.","edition":"3"},{"key":"508_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271\u201392.","journal-title":"J Health Econ"},{"key":"508_CR18","doi-asserted-by":"publisher","first-page":"5023973","DOI":"10.1155\/2016\/5023973","volume":"2016","author":"G Huppertz-Hauss","year":"2016","unstructured":"Huppertz-Hauss G, Aas E, Lie Hoivik M, Langholz E, Odes S, Smastuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T. Comparison of the multiattribute utility instruments EQ-5D and SF-6D in a Europe-wide population-based cohort of patients with inflammatory bowel disease 10 years after diagnosis. Gastroenterol Res Pract. 2016;2016:5023973.","journal-title":"Gastroenterol Res Pract"},{"key":"508_CR19","doi-asserted-by":"publisher","first-page":"e000106","DOI":"10.1136\/bmjgast-2016-000106","volume":"3","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Stepanova M, Pham H, Noor B, Walters M, Younossi ZM. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol. 2016;3:e000106.","journal-title":"BMJ Open Gastroenterol"},{"key":"508_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"508_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353\u201365.","journal-title":"PharmacoEconomics"},{"key":"508_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3109\/09513590.2013.831833","volume":"29","author":"LM Pompei","year":"2013","unstructured":"Pompei LM, Fernandes CE, Steiner ML, Strufaldi R, Melo NR. Attitudes, knowledge and prescribing habits of Brazilian gynecologists regarding extended-cycle oral contraceptives. Gynecol Endocrinol. 2013;29:1071\u20134.","journal-title":"Gynecol Endocrinol"},{"key":"508_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2147\/IJWH.S51329","volume":"5","author":"U Sauer","year":"2013","unstructured":"Sauer U, Mann S, Brima N, Stephenson J. Offering extended use of the combined contraceptive pill: a survey of specialist family planning services. Int J Womens Health. 2013;5:613\u20137.","journal-title":"Int J Womens Health."},{"key":"508_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/13625187.2010.518708","volume":"15","author":"I Wiegratz","year":"2010","unstructured":"Wiegratz I, Galilaer K, Sanger N, Rody A, Kuhl H, Schleussner E. Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives. Eur J Contracept Reprod Health Care. 2010;15:405\u201312.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"508_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.contraception.2010.11.004","volume":"84","author":"R Burkman","year":"2011","unstructured":"Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception. 2011;84:19\u201334.","journal-title":"Contraception"},{"key":"508_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32526-9","volume":"29","author":"E Guilbert","year":"2007","unstructured":"Guilbert E, Boroditsky R, Black A, Kives S, Leboeuf M, Mirosh M, Senikas V, Wagner MS, Weir E, York-Lowry J, Reid R, Trussell J. Canadian consensus guideline on continuous and extended hormonal contraception, 2007. J Obstet Gynaecol Can. 2007;29:S1\u2013S32.","journal-title":"J Obstet Gynaecol Can"},{"key":"508_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1743-6109.2012.03004.x","volume":"10","author":"S Caruso","year":"2013","unstructured":"Caruso S, Malandrino C, Cicero C, Ciancio F, Cariola M, Cianci A. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study. J Sex Med. 2013;10:460\u20136.","journal-title":"J Sex Med"},{"key":"508_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.fertnstert.2011.04.095","volume":"96","author":"J Fourquet","year":"2011","unstructured":"Fourquet J, Baez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril. 2011;96:107\u201312.","journal-title":"Fertil Steril"},{"key":"508_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","volume":"96","author":"KE Nnoaham","year":"2011","unstructured":"Nnoaham KE, Hummelshoj L, Webster P, D'Hooghe T, de Cicco NF, de Cicco NC, Jenkinson C, Kennedy SH, Zondervan KT. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96:366\u201373.","journal-title":"Fertil Steril"},{"key":"508_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/jwh.2012.3633","volume":"22","author":"R Wasiak","year":"2013","unstructured":"Wasiak R, Filonenko A, Vanness DJ, Law A, Jeddi M, Wittrup-Jensen KU, Stull DE, Siak S, Jensen JT. Impact of estradiol valerate\/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding. J Women's Health. 2013;22:378\u201384.","journal-title":"J Women's Health"},{"key":"508_CR31","first-page":"271","volume":"4","author":"R Wasiak","year":"2012","unstructured":"Wasiak R, Filonenko A, Vanness DJ, Wittrup-Jensen KU, Stull DE, Siak S, Fraser I. Impact of estradiol-valerate\/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding. Int J Womens Health. 2012;4:271\u20138.","journal-title":"Int J Womens Health"},{"key":"508_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/154099903770948140","volume":"12","author":"K Barnard","year":"2003","unstructured":"Barnard K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J Women's Health. 2003;12:911\u20139.","journal-title":"J Women's Health"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-017-0508-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T19:06:06Z","timestamp":1547751966000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-017-0508-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/s12905-017-0508-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"23 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Electronic consent was obtained from all participants in the NHWS. The survey was granted exemption by the Essex Institutional Review Board (Lebanon, NJ). Essex Institutional Review Board, Lebanon, NJ, USA reviewed and approved the US NHWS 2013 survey","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"REN is a consultant and\/or speaker for Bayer Pharma, Eli Lilly, Gedeon Richter, HRA Pharma, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Shionogi, Teva, and Zambon SpA; IL is a consultant and\/or speaker for HRA Pharma, Merck Sharp & Dohme, Nordic, and Teva; LKL is a full-time employee of Kantar Health, which received funding to conduct this study; NMF was a full-time employee of Kantar Health at the time this study was conducted; MCM is a consultant for Teva Europe Medical Affairs; BT is an employee of Teva Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"22"}}